Regulatory Updates
Sep 28, 2026•1 min read
Seoul Pharmacists Association Calls for Safety‑First Rules on Telemedicine Drug Delivery and Standby Medicine Expansion
Ahead of a national audit, the Seoul City Pharmacists Association urged the National Assembly to prioritize patient safety and strengthen oversight before expanding telemedicine drug delivery and safety‑standby medicines.
Regulatory Updates
Sep 25, 2026•1 min read
Korean Pharmacists Mobilize to Halt Expansion of Remote Drug Delivery
Pharmacists and civil groups in South Korea are staging protests and a nationwide rally after a petition against remote prescription drug delivery gathered 50,000 signatures.
Regulatory Updates
Sep 23, 2026•1 min read
Korean Pharmacists Association Calls for Withdrawal of Remote Prescription Day Limit and Drug Delivery Expansion
The Korean Pharmacists Association urges the government to scrap the 7‑day limit on first‑time telemedicine prescriptions and the planned expansion of drug delivery, citing patient safety.
Regulatory Updates
Sep 18, 2026•1 min read
Health Canada Warns of Counterfeit Soprano Laser Hair Removal Devices Sold to Canadian Clinics
Health Canada alerts that counterfeit laser hair removal devices marketed as “Soprano” are being sold to clinics in Canada, posing health risks and violating regulations.
Regulatory Updates
Sep 17, 2026•1 min read
Trinity Biotech Recalls Oxalate Reagent B (Lot 2500711) Due to Performance Variability
Trinity Biotech is recalling Oxalate Reagent B (Product Code 591-2, Lot 2500711) because of performance variability causing negative bias and under‑recovery of oxalate values, potentially yielding falsely low patient results.
Regulatory Updates
Sep 17, 2026•1 min read
Trinity Biotech Recalls Oxalate Reagent B Lot 2500711 – Health Canada
Trinity Biotech is recalling Oxalate Reagent B (Product Code 591-2, Lot 2500711) due to performance variability that may produce falsely low oxalate results. Users should stop use and quarantine inventory.
Regulatory Updates
Sep 16, 2026•1 min read
MHRA Alert: Patient Hoists and Slings Pose Fatal Fall Risk
MHRA reports ongoing fatal and serious harm from patient falls involving hoists or slings, noting an average of two deaths in recent incidents.
Regulatory Updates
Sep 14, 2026•1 min read
Dementia Patient Missing Reports Reach 73,313; Fingerprint Pre‑Registration Stagnates at 50.2%
Data from police and health ministry show 73,313 dementia‑patient missing reports from 2022 to June 2024, while cumulative fingerprint pre‑registration remains at 50.2%.
Regulatory Updates
Sep 14, 2026•1 min read
Guro‑gu Pharmaceutical Association Urges Caution on Expanding Telemedicine Prescription Delivery
The Guro‑gu Pharmacy Association delivered local pharmacists’ concerns to the National Assembly, warning that a full rollout of remote prescription delivery could impact community pharmacy networks and patient safety.
Regulatory Updates
Sep 13, 2026•1 min read
Consumer group urges safety review of telemedicine drug delivery
Health Consumer Solidarity says expanding drug delivery for telemedicine must be preceded by a thorough safety and outcome review, prioritizing public health over convenience.
Regulatory Updates
Sep 10, 2026•1 min read
GE Healthcare alerts on two potential issues in Centricity High Acuity systems
GE Healthcare reports two potential safety issues affecting order summary components in certain Centricity High Acuity anesthesia systems.
Regulatory Updates
Sep 10, 2026•1 min read
Government to Expand Telemedicine Drug Delivery, Calls for Safety and Liability Framework
Korea plans to broaden medication delivery for telemedicine patients, prompting calls to address safety risks and clarify liability among pharmacies, platforms and couriers.